Scinovex
articleTop 10% cited

Double‐blind comparison of an oral <i>Escherichia coli</i> preparation and mesalazine in maintaining remission of ulcerative colitis

Alimentary Pharmacology & Therapeutics · 1997 · Vol. 11(5) · pp. 853–858
Wolfgang KruisE. SCHÜTZP FričB FixaG JudmaierM. Stolte

Abstract

From the results of this preliminary study, probiotic treatment appears to offer another option for maintenance therapy of ulcerative colitis. Additional support is provided for the hypothesis of a pathophysiological role for the intestinal environment in ulcerative colitis.

Inflammatory Bowel DiseaseGut microbiota and healthPharmacological Effects of Natural CompoundsMesalazineUlcerative colitisMedicineInternal medicineGastroenterologyTolerabilityProbioticAdverse effectColitisInflammatory bowel disease

MeSH terms

AdultAgedAged, 80 and overAnti-Inflammatory Agents, Non-SteroidalColitis, UlcerativeDouble-Blind MethodEscherichia coliFemaleHumansMaleMiddle AgedMesalamineProbioticsSecondary Prevention
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.